Launching at MMC - Aspergillus Galactomannan EIA - . “Galactomannan Screening for the Early Diagnosis of Invasive Aspergillosis” Dr. Vilma M. Co / Dr. Demetrio Valle Pledge of Support – Pfizer / Lifeline Message of Acceptance – Makati Medical Center Ceremonial MOA Signing
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
“Galactomannan Screening for the Early Diagnosis of Invasive Aspergillosis”
Dr. Vilma M. Co / Dr. Demetrio Valle
- a condition where the fungus causes allergic respiratory symptoms, such as wheezing and coughing, but does not actually invade and destroy tissue.
- a disease that usually affects people with immune system problems.
- the fungus invades and damages tissues in the body.
- most commonly affects the lungs, but can also cause infection in many other organs & can spread throughout the body.
KEY BENEFITS :
Screening high-risk patients with PlateliaTMAspergillus EIA, twice-weekly, provides early diagnosis of IA.
Comparison to Other Diagnostic Methods :
J.Maertens JID 2002